AI Pathology
aetherAI alternatives
13 tools that we compared head to head with aetherAI in a written verdict. Each row says who the tool suits, according to that verdict, and links to the full comparison.
The list is not a ranking. Tools in the same category come first, then every group is in alphabetical order. A tool that is no longer sold is left out.
Aiforia
CE-IVD prostate biopsy suite, IVDR reported February 2025; iSO 27001 and SOC 2 Type II
See the review for plans
Full comparison
Artera
Prostate De Novo DEN240068, breast 510(k) K254115; sOC 2 Type II and HIPAA on homepage
See the review for plans
Full comparison
Caris Life Sciences
FDA-approved MI Cancer Seek profiling, PMA P240010; eHR ordering at 3,100+ locations, vendor claim
See the review for plans
Full comparison
Freenome
PMA P250029 blood test for average-risk adults 45 and up; abbott to commercialize exclusively in the US
See the review for plans
Full comparison
GRAIL
Galleri multi-cancer blood test for adults 50 and older; panel vote 7 yes, 2 no, 1 abstention on benefit-risk
See the review for plans
Full comparison
Ibex Medical Analytics
Prostate Detect 510(k) K241232, January 2025; vendor-stated open API to scanners, image management, LIS
See the review for plans
Full comparison
Indica Labs HALO AI
HALO AP Dx cleared with Aperio GT 450 DX and NanoZoomer; hALO Prostate AI is CE-IVD marked
See the review for plans
Full comparison
PathAI AISight
AISight Dx cleared for primary diagnosis, K243391; cE-IVD for EEA, UK and Switzerland
See the review for plans
Full comparison
Proscia Concentriq
Two 510(k)s, Hamamatsu then Leica Aperio GT 450 DX; sOC 2 Type II announced December 2025
See the review for plans
Full comparisonSectra Pathology
Amplifier marketplace for third-party AI on one contract; k232208 with DICOM support and Leica GT 450 DX
See the review for plans
Full comparison
Tempus Digital Pathology
Paige FullFocus viewer 510(k)s plus Prostate Detect De Novo; prostate Detect also carries CE-IVDR
See the review for plans
Full comparison
Vesta
BCG response estimate from routine H&E slides; vendor says results about 3 days after sample arrives
See the review for plans
Full comparison
Visiopharm
Vendor says IVDR-certified apps cover breast, lung and prostate; eR, PR, HER2 and Ki-67 apps with IMS and LIMS integration
See the review for plans
Full comparison